BioWorld-International-2006-01-11
Symphogen Gets $25M, As Antibody Products Progress
Symphogen Gets $25M, As Antibody Products Progress
Symphogen A/S raised $25 million in a Series D funding that attracted one new investor. (BioWorld International)

